Immunome Inc. Quarterly Assets in USD from Q4 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Immunome Inc. quarterly Assets history and growth rate from Q4 2019 to Q3 2024.
Immunome Inc. Assets for the quarter ending September 30, 2024 was $257M, a 176% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$257M	+$164M	+176%	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	$296M	+$255M	+615%	Jun 30, 2024	10-Q	2024-08-12
Q1 2024	$320M	+$272M	+565%	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$149M	+$124M	+518%	Dec 31, 2023	10-Q	2024-11-13
Q3 2023	$93.2M	+$62.6M	+205%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$41.4M	+$2.42M	+6.19%	Jun 30, 2023	10-Q	2023-08-09
Q1 2023	$48.1M	+$386K	+0.81%	Mar 31, 2023	10-Q	2023-05-05
Q4 2022	$24M	-$33.9M	-58.5%	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$30.5M	-$32M	-51.2%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$39M	-$25.1M	-39.2%	Jun 30, 2022	10-Q	2022-08-05
Q1 2022	$47.7M	+$5.14M	+12.1%	Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$57.9M	+$13.4M	+30.1%	Dec 31, 2021	10-K	2023-03-16
Q3 2021	$62.6M	+$50.6M	+422%	Sep 30, 2021	10-Q	2021-11-15
Q2 2021	$64.1M			Jun 30, 2021	10-Q	2021-08-16
Q1 2021	$42.6M			Mar 31, 2021	10-Q	2021-05-12
Q4 2020	$44.5M	+$39.5M	+780%	Dec 31, 2020	10-K	2022-03-28
Q3 2020	$12M			Sep 30, 2020	10-Q	2020-11-16
Q4 2019	$5.06M			Dec 31, 2019	10-K	2021-03-25

* An asterisk sign (*) next to the value indicates that the value is likely invalid.